Pasternak Richard C 4
4 · Milestone Pharmaceuticals Inc. · Filed Nov 14, 2019
Insider Transaction Report
Form 4
Pasternak Richard C
Director
Transactions
- Award
Stock Option (right to buy)
2019-11-12+19,000→ 19,000 totalExercise: $17.78Exp: 2029-11-12→ Common Shares (19,000 underlying)
Footnotes (1)
- [F1]This option will vest in equal monthly installments, beginning on December 12, 2019, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date.